Related Experiment Video
Updated: Apr 22, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
6.5K
Toward better benchmarking: challenge-based methods assessment in cancer genomics
Genome Biology
|October 16, 2014
Summary
Challenge-based assessments using crowd-sourcing can improve the evaluation of cancer genomics algorithms. This approach helps distribute effort and reduce bias in analyzing complex genomic data.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Rapid advancements in technology necessitate robust evaluation methods for cancer genomics data analysis algorithms.
- Existing evaluation frameworks may not adequately address the complexity and scale of modern genomic datasets.
Purpose of the Study:
- To propose and outline a novel approach for evaluating algorithms used in cancer genomics data analysis.
- To highlight the potential of challenge-based assessment and crowd-sourcing to enhance algorithm evaluation.
Main Methods:
- Leveraging crowd-sourcing to distribute the effort of algorithm assessment.
- Implementing challenge-based assessment frameworks to standardize and scale evaluation.
- Focusing on reducing bias inherent in traditional evaluation methods.
Main Results:
- Challenge-based assessment offers a scalable solution for evaluating numerous cancer genomics algorithms.
- Crowd-sourcing distributes the computational and analytical workload, making evaluation more efficient.
- This methodology can mitigate biases, leading to more reliable algorithm performance metrics.
Conclusions:
- Challenge-based assessment combined with crowd-sourcing presents a promising strategy for the rigorous evaluation of cancer genomics algorithms.
- This approach addresses the urgent need for improved, unbiased, and scalable evaluation methods in the field.
Related Concept Videos
Cancer Survival Analysis
855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Cancer-Critical Genes II: Tumor Suppressor Genes
7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K

